Silver Book Fact

Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.

Alzheimer's Association. 2011 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2011; 7(2): 208-44. http://www.alzheimersanddementia.com/article/S1552-5260(11)00036-7/fulltext

Reference

Title
2011 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2011
Authors
Alzheimer's Association
Volume & Issue
Volume 7, Issue 2
Pages
208-44
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • Slowing the progression of Parkinson’s disease by just 10% would save $327 million (in direct and indirect costs) to the U.S. annually.  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • Delaying the onset and progression of Alzheimer’s disease would reduce the projected number of people with moderate to severe cases of the disase to 4.4 million instead of 10.3 million…  
  • Early Gene Therapy Studies Show Promise for Parkinson’s Disease